Company profile: Betagenon
1.1 - Company Overview
Company description
- Provider of AMPK activator compound development to treat chronic energy balance disorders in metabolically challenged elderly and/or obese individuals, with expected beneficial effects on metabolic and cardiovascular diseases; a Sweden-based biopharmaceutical company.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Betagenon
HighTide Therapeutics
HQ: China
Website
- Description: Provider of global clinical-stage biopharmaceutical drug development, centered on HTD1801, a candidate targeting NASH, type 2 diabetes (T2DM), severe hypertriglyceridemia (SHTG), primary sclerosing cholangitis (PSC), and primary biliary cholangitis (PBC). Conducts multi-regional clinical trials, including a Phase 2b study for NASH and a Phase 3 study for T2DM.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full HighTide Therapeutics company profile →
Metacrine
HQ: United States
Website
- Description: Provider of clinical-stage biopharmaceutical research and development focused on building an innovative pipeline of best-in-class drugs.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Metacrine company profile →
Unicycive Therapeutics
HQ: United States
Website
- Description: Provider of kidney disease therapeutics development programs addressing unmet medical needs, including UNI-494, a patented pro-drug of nicorandil in development for acute kidney injury to improve mitochondrial function, and Oxylanthanum Carbonate, an investigational drug under FDA’s 505(b)(2) for hyperphosphatemia using nanoparticle technology to potentially reduce pill burden.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Unicycive Therapeutics company profile →
Rediscovery Life Sciences
HQ: United States
Website
- Description: Provider of biopharma drug development, creating medicines with less risk through drug repurposing.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Rediscovery Life Sciences company profile →
Humedics
HQ: Germany
Website
- Description: Provider of rapid, precise liver function measurement via LiMAx, an easy-to-use bedside, non-invasive breath analysis test using 13C-labelled methacetin to assess liver function capacity. Offers LiMAx device development for surgical use with potential expansion into general healthcare, and supports investigator-initiated research. Applications include planning liver surgeries, patient selection, postoperative management, and assessing disease severity.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Humedics company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Betagenon
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Betagenon
2.2 - Growth funds investing in similar companies to Betagenon
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Betagenon
4.2 - Public trading comparable groups for Betagenon
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →